Balyasny Asset Management L.P. Takes $79,000 Position in DiaMedica Therapeutics Inc. (NASDAQ:DMAC)
Balyasny Asset Management L.P. bought a new stake in shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 14,581 shares of the company’s stock, valued at approximately $79,000. Other institutional investors and hedge funds […]
Balyasny Asset Management L.P. bought a new stake in shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 14,581 shares of the company’s stock, valued at approximately $79,000. Other institutional investors and hedge funds […]
